Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
India · Delayed Price · Currency is INR 3,135.00
-59.50 (-1.86%)
Sep 29, 2025, 3:30 PM IST
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 266.78 billion as of September 29, 2025. Its market cap has decreased by -5.20% in one year.
Market Cap
266.78B
Enterprise Value
257.05B
Revenue
25.29B
Ranking
n/a
PE Ratio
51.95
Stock Price
3,135.00
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 266.78B, an increase of 291.27%. That is a compound annual growth rate of 14.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 266.78B | 6.71% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | 190.13B | 54.56% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 3,807.02B |
| Divi's Laboratories | 1,510.38B |
| Cipla | 1,211.15B |
| Apollo Hospitals Enterprise | 1,079.82B |
| Mankind Pharma | 1,024.84B |
| Zydus Lifesciences | 981.08B |
| Fortis Healthcare | 704.19B |
| Alkem Laboratories | 649.60B |